Cantitate/Preț
Produs

Immunopotentiators in Modern Vaccines

Editat de Virgil Schijns, Derek O'Hagan
en Limba Engleză Hardback – 10 noi 2016
Immunopotentiators in Modern Vaccines, Second Edition, provides in-depth insights and overviews of the most successful adjuvants, those that have been included in licensed products, also covering the most promising technologies that have emerged in recent years. In contrast to existing books on the subject, the chapters here provide summaries of key data on the mechanisms of action of the individual vaccine adjuvants.
In addition, the book covers key aspects of how the technologies might be further developed and what might be their limitations, while also giving an overview of what made the most advanced adjuvant technologies successful.


  • Provides contributions from leading international authorities in the field
  • Features immunopotentiators classified by function, with well-illustrated, informative figures presenting the interaction between the immunopotentiators and the host immune system
  • Lists advantages and potential hurdles for achieving a practical application for each specific immunopotentiator
  • Offers US FDA perspectives which highlight how future adjuvants will be approved for new generation vaccines
Citește tot Restrânge

Preț: 68940 lei

Preț vechi: 85626 lei
-19% Nou

Puncte Express: 1034

Preț estimativ în valută:
13194 13705$ 10959£

Carte tipărită la comandă

Livrare economică 27 ianuarie-10 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128040195
ISBN-10: 012804019X
Pagini: 508
Dimensiuni: 191 x 235 x 31 mm
Greutate: 1.2 kg
Ediția:2 Rev ed.
Editura: ELSEVIER SCIENCE

Cuprins

1. Vaccine Adjuvants' Mode of Action: Unraveling ‘‘the Immunologist's Dirty Little Secret” 2. The Role of Inflammasomes in Adjuvant-Driven Humoral and Cellular Immune Responses 3. Dendritic Cells as Targets of Vaccines and Adjuvants 4. Host-Derived Cytokines and Chemokines as Vaccine Adjuvants 5. Discovery of Immune Potentiators as Vaccine Adjuvants 6. Current Status of Toll-Like Receptor 4 Ligand Vaccine Adjuvants 7. Flagellins as Adjuvants of Vaccines 8. Toll-Like Receptor 7 and 8 Agonists for Vaccine Adjuvant Use 9. CpG Oligodeoxynucleotides as Adjuvants for Clinical Use 10. Advax Adjuvant: A Potent and Safe Immunopotentiator Composed of Delta Inulin 11. Natural Vaccine Adjuvants and Immunopotentiators Derived From Plants, Fungi, Marine Organisms, and Insects 12. Polymeric Particles as Vaccine Delivery Systems 13. MF59: A Safe and Potent Adjuvant for Human Use 14. The Development of the Adjuvant System AS01: A Combination of Two Immunostimulants MPL and QS-21 in Liposomes 15. Development and Evaluation of AS04, a Novel and Improved Adjuvant System Containing 3-O-Desacyl-4′- Monophosphoryl Lipid A and Aluminum Salt 16. ISCOMATRIX Adjuvant in the Development of Prophylactic and Therapeutic Vaccines 17. Development and Evaluation of CAF01 18. Mineral Adjuvants 19. Toxin-Based Mucosal Adjuvants 20. Adjuvants for Skin Vaccination 21. Vaccination to Treat Noninfectious Diseases: Surveying the Opportunities 22. A Framework for Evaluating Nonclinical Safety of Novel Adjuvants and Adjuvanted Preventive Vaccines